Abstract:We report on using the synthetic aminoadamantane-CH2-aryl derivatives 1–6 as sensitive probes for blocking M2 S31N and influenza A virus (IAV) M2 wild-type (WT) channels as well as virus replication in cell culture. The binding kinetics measured using electrophysiology (EP) for M2 S31N channel are very dependent on the length between the adamantane moiety and the first ring of the aryl headgroup realized in 2 and 3 and the girth and length of the adamantane adduct realized in 4 and 5. Study of 1–6 shows that, according to molecular dynamics (MD) simulations and molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) calculations, all bind in the M2 S31N channel with the adamantyl group positioned between V27 and G34 and the aryl group projecting out of the channel with the phenyl (or isoxazole in 6) embedded in the V27 cluster. In this outward binding configuration, an elongation of the ligand by only one methylene in rimantadine 2 or using diamantane or triamantane instead of adamantane in 4 and 5, respectively, causes incomplete entry and facilitates exit, abolishing effective block compared to the amantadine derivatives 1 and 6. In the active M2 S31N blockers 1 and 6, the phenyl and isoxazolyl head groups achieve a deeper binding position and high kon/low koff and high kon/high koff rate constants, compared to inactive 2–5, which have much lower kon and higher koff. Compounds 1–5 block the M2 WT channel by binding in the longer area from V27–H37, in the inward orientation, with high kon and low koff rate constants. Infection of cell cultures by influenza virus containing M2 WT or M2 S31N is inhibited by 1–5 or 1–4 and 6, respectively. While 1 and 6 block infection through the M2 block mechanism in the S31N variant, 2–4 may block M2 S31N virus replication in cell culture through the lysosomotropic effect, just as chloroquine is thought to inhibit SARS-CoV-2 infection.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00553?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00553</a>.Methods (for electrophysiology, anti-viral testing, simulations, and synthetic procedures including the characterization of compounds 1−5), EP results for 1 against the S31 channels of A/Calif/07/2009 M2 N31S and A/Udorn/72 M2 WT, RMSDs from MD simulations, molecular docking and MM-PBSA, SMD calculation results (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00553/suppl_file/cb0c00553_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Chemical Probes for Blocking of Influenza A M2 Wild-type and S31N Channels

Adamantyl Amines Activity Study Against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple blocker Explored with MD simulations and Solid state NMR

Amantadine Variants Activity Against Multiple Influenza A Viruses

Front Cover: A Study of the Activity of Adamantyl Amines against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple Blocker, Explored by Molecular Dynamics Simulations and Solid‐State NMR (ChemMedChem 16/2023)

Antiviral Mechanisms and Preclinical Evaluation of Amantadine Analogs that Continue to Inhibit Influenza A Viruses with M2 -Based Drug Resistance

Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.

Design and Synthesis of Pinanamine Derivatives As Anti-Influenza A M2 Ion Channel Inhibitors

Isocyanides As Influenza A Virus Subtype H5N1 Wild‐Type M2 Channel Inhibitors

New Strategy for High Throughput Screening of Anti-Influenza Virus M2 Ion Channel Inhibitors.

Heterodimers of Histidine and Amantadine As Inhibitors for Wild Type and Mutant M2 Channels of Influenza A

X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance

Structural comparison of the wild-type and drug-resistant mutants of the influenza A M2 proton channel by molecular dynamics simulations.

Structural Basis for Interactions between Influenza A Virus M2 Proton Channel and Adamantane-Based Antiviral Drugs

Characterization of Inhibition of M2 Ion Channel Activity by BL-1743, an Inhibitor of Influenza A Virus.

Mechanism of drug inhibition and drug resistance of influenza A M2 channel

X-Ray Crystal Structure Of The Influenza A M2 Proton Channel S31n Mutant In Two Conformational States: An Open And Shut Case

Virtual Screening and Molecular Growth Guide the Design of Inhibitors for the Influenza Virus Drug-Resistant Mutant M2-V27A/S31N.

Insights from Investigating the Interactions of Adamantane-Based Drugs with the M2 Proton Channel from the H1N1 Swine Virus

An effective molecular blocker of ion channel of M2 protein as anti-influenza a drug

Design and synthesis of pinane oxime derivatives as novel anti-influenza agents

Structural and Energetic Analysis of Drug Inhibition of the Influenza A M2 Proton Channel